Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001570562-24-000138
Filing Date
2024-12-26
Accepted
2024-12-26 17:28:08
Documents
1
Period of Report
2024-12-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1735252082.html 4  
1 FORM 4 wk-form4_1735252082.xml 4 3445
  Complete submission text file 0001570562-24-000138.txt   4944
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Issuer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O OBALON THERAPEUTICS, INC. 5421 AVENIDA ENCINAS, SUITE F CARLSBAD CA 92008
Business Address
MOATAZEDI DAVID (Reporting) CIK: 0001700836 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38381 | Film No.: 241581812